SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-014858
Filing Date
2020-08-06
Accepted
2020-08-06 16:16:11
Documents
85
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1768167
2 ex10-1.htm EX-10.1 65088
3 ex10-2.htm EX-10.2 357701
4 ex31-1.htm EX-31.1 17823
5 ex31-2.htm EX-31.2 17678
6 ex32-1.htm EX-32.1 9040
  Complete submission text file 0001493152-20-014858.txt   9438248

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE lctx-20200630.xsd EX-101.SCH 75251
8 XBRL CALCULATION FILE lctx-20200630_cal.xml EX-101.CAL 75746
9 XBRL DEFINITION FILE lctx-20200630_def.xml EX-101.DEF 339590
10 XBRL LABEL FILE lctx-20200630_lab.xml EX-101.LAB 539626
11 XBRL PRESENTATION FILE lctx-20200630_pre.xml EX-101.PRE 446522
12 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1602411
Mailing Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008 5105213390
Lineage Cell Therapeutics, Inc. (Filer) CIK: 0000876343 (see all company filings)

IRS No.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12830 | Film No.: 201081851
SIC: 2836 Biological Products, (No Diagnostic Substances)